stoxline Quote Chart Rank Option Currency Glossary
Sera Prognostics, Inc. (SERA)
5.05  -0.44 (-8.01%)    12-07 16:00
Open: 4.75
High: 5.67
Volume: 3,805,161
Pre. Close: 5.49
Low: 4.71
Market Cap: 158(M)
Technical analysis
2023-12-07 4:23:18 PM
Short term     
Mid term     
Targets 6-month :  7.85 1-year :  11.51
Resists First :  6.72 Second :  9.85
Pivot price 2.36
Supports First :  1.64 Second :  1.37
MAs MA(5) :  3.32 MA(20) :  2.2
MA(100) :  2.12 MA(250) :  2.57
MACD MACD :  0.5 Signal :  0.1
%K %D K(14,3) :  56.4 D(3) :  63.1
RSI RSI(14): 82.6
52-week High :  9.85 Low :  1.1
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ SERA ] has closed above the upper band by 8.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 570.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 5.67 - 5.7 5.7 - 5.72
Low: 4.65 - 4.68 4.68 - 4.7
Close: 5 - 5.05 5.05 - 5.09
Company Description

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Headline News

Thu, 07 Dec 2023
Sera Prognostics Inc (SERA) is up 2.91% Thursday In Premarket Trading - InvestorsObserver

Thu, 07 Dec 2023
While institutions invested in Sera Prognostics, Inc. (NASDAQ:SERA) benefited from last week's 183% gain, retail ... - Yahoo Finance

Wed, 06 Dec 2023
Top Midday Gainers -December 06, 2023 at 02:28 pm EST -

Wed, 06 Dec 2023
Sector Update: Health Care -December 06, 2023 at 02:02 pm EST -

Wed, 06 Dec 2023
Why Is Preterm Birth Risk Kit Focused Sera Prognostics Stock Trading Higher Today? - Sera Prognostics (NA - Benzinga

Wed, 06 Dec 2023
Sera Prognostics shares rocket 160% on PreTRM study update (SERA) - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Diagnostics & Research
Shares Out 0 (M)
Shares Float 30 (M)
Held by Insiders 2.019e+007 (%)
Held by Institutions 15 (%)
Shares Short 237 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -4e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -19 %
Return on Assets (ttm) 485.7 %
Return on Equity (ttm) -24.8 %
Qtrly Rev. Growth 330000 %
Gross Profit (p.s.) -178.28
Sales Per Share -143.8
EBITDA (p.s.) 258621
Qtrly Earnings Growth -1.3 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -28 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.04
Price to Cash Flow 0.6
Stock Dividends
Dividend 0
Forward Dividend 216850
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android